Alliance for a Stronger FDA (Formerly FDA Alliance)
a 501(c)(4) organization advocating for increased appropriated resources for the FDA
Based in MD
AI Overview
With $505K in lobbying spend across 30 quarterly filings, Alliance for a Stronger FDA (Formerly FDA Alliance) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $80K |
| 2020 | $90K |
| 2021 | $60K |
| 2022 | $60K |
| 2023 | $60K |
| 2024 | $75K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alliance for a Stronger FDA (Formerly FDA Alliance) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
To increase appropriated resources available to the US Food and Drug Administration
To increase the appropriated funding available to the US Food and Drug Administration
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.